Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Lok Sabha

    Tag: Lok Sabha

    You Searched For "Lok Sabha"
    Price of 21 essential drugs went up  in 2019, Details

    Price of 21 essential drugs went up in 2019, Details

    MD bureau8 Feb 2020 2:03 PM IST
    "It was noted that the twenty-one scheduled formulations considered for upward price revision under para 19 of DPCO, 2013 are low priced drugs and...
    Overcharging on Anti-diabetic, Cardiac Care Drugs: Rs 245.96 crore recovered from Pharma Firms, Minister informs Parliament

    Overcharging on Anti-diabetic, Cardiac Care Drugs: Rs 245.96 crore recovered from Pharma Firms, Minister informs Parliament

    Farhat Nasim6 Feb 2020 4:43 PM IST
    NPPA has detected and issued about 162 demand notices against the pharmaceutical companies for overcharging consumers on the sale of Anti-diabetic and...
    Minister informs Parliament about steps taken to promote affordable generic drugs

    Minister informs Parliament about steps taken to promote affordable generic drugs

    Medical Dialogues Bureau26 Nov 2019 4:30 PM IST
    New Delhi: The Minister in the Ministry of Chemicals and Fertilizers D V Sadananda Gowda recently informed the Parliament about the steps taken by the...
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 12:16 PM IST
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
    Definition of generic drugs discussed in Parliament

    Definition of generic drugs discussed in Parliament

    Farhat Nasim7 July 2019 9:50 AM IST
    He said that the generic medicines are generally those which contain some amount of same active ingredients in same dosage form, and are intended to...
    Drugmakers cannot raise price of non-scheduled formulations by more than 10 pc yearly: Minister informs Parliament

    Drugmakers cannot raise price of non-scheduled formulations by more than 10 pc yearly: Minister informs Parliament

    Medical Dialogues Bureau5 July 2019 5:58 PM IST
    As per provisions of DPCO, all manufacturers of Scheduled medicines (branded or generic) have to sell their products within the ceiling price fixed by...
    More than 10 percent of Drug samples from Government sources Not of Standard Quality

    More than 10 percent of Drug samples from Government sources Not of Standard Quality

    Meghna A Singhania25 Jun 2019 3:43 PM IST
    New Delhi: Estimated 10.02% medicines of the sample of medicines from government sources tested by the government were found to be Not of Standard...
    Labeling Norms For Generic Drugs: Health Minister apprises parliament

    Labeling Norms For Generic Drugs: Health Minister apprises parliament

    Ruby Khatun Khatun11 March 2018 11:56 AM IST
    New Delhi: The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about the...
    1,179 Ayush drug manufacturers not compliant with Good Manufacturing Practices: Govt

    1,179 Ayush drug manufacturers not compliant with Good Manufacturing Practices: Govt

    Ruby Khatun Khatun20 Dec 2017 3:58 PM IST
    New Delhi: There are 8,667 licenced Ayurvedic, Siddha, Unani and Homoeopathy (ASU&H) drug manufacturers in the country, out of which 1,179 are...
    China accounts for 66 percent of India

    China accounts for 66 percent of India's bulk drug imports in FY'17

    Ruby Khatun Khatun20 Dec 2017 10:15 AM IST
    New Delhi: India's bulk drug imports from top five countries stood at Rs 18,372.54 crore in 2016-17 with China accounting for 66 percent, Parliament...
    Pharma, medical devices should be under one ministry: Mansukh L Mandaviya

    Pharma, medical devices should be under one ministry: Mansukh L Mandaviya

    Ruby Khatun Khatun10 Aug 2017 10:00 AM IST
    New Delhi: The Department of Pharmaceuticals (DoP) feels that subjects and regulatory bodies related to pharmaceuticals and medical devices should...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok